PCI for STEMI - The Cardiology Advisor
Health Economic Evaluation of an Ultrathin, Bioresorbable-Polymer Sirolimus-Eluting Coronary Stent Compared to a Thin, Durable-Polymer Everolimus-Eluting Stent - ScienceDirect
Cost implications of intraprocedural thrombotic events and bleeding in percutaneous coronary intervention: Results from the CHAMPION PHOENIX ECONOMICS Study | Semantic Scholar
Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention
TCT 79: Efficacy of Cangrelor in Lesions With High-Risk and Low-Risk Angiographic Characteristics – The CHAMPION PHOENIX Trial | tctmd.com
Cathlab & Cardiovascular News
The evolution of antiplatelet therapy in cardiovascular disease | Nature Reviews Cardiology
Cost implications of intraprocedural thrombotic events and bleeding in percutaneous coronary intervention: Results from the CHAMPION PHOENIX ECONOMICS Study | Semantic Scholar
Stent Thrombosis: A Clinical Perspective | JACC: Cardiovascular Interventions
Cardiovascular Medicine - Current trends in dual antiplatelet therapy: a 2017 update
Study flow diagram. | Download Scientific Diagram
Intra-Procedural Stent Thrombosis: A New Risk Factor for Adverse Outcomes in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndromes | JACC: Cardiovascular Interventions
Complications of Coronary Artery Interventions: Overview | SpringerLink
Antiplatelet Drugs in the Management of Coronary Artery Disease - ScienceDirect
Cangrelor for treatment during percutaneous coronary intervention | Future Cardiology
Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention: Insights From the CHAMPION PHOENIX Trial (Clinical Trial Comparing Cangrelor to Clopidogrel Standard of Care Therapy in Subjects Who Require Percutaneous Coronary ...
2014 ESC/EACTS Guidelines on myocardial revascularization – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.
Antithrombotic Approaches in Acute Coronary Syndromes: Optimizing Benefit vs Bleeding Risks - ScienceDirect
Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention: Insights From the CHAMPION PHOENIX Trial (Clinical Trial Comparing Cangrelor to Clopidogrel Standard of Care Therapy in Subjects Who Require Percutaneous Coronary ...
Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention: Insights From the CHAMPION PHOENIX Trial (Clinical Trial Comparing Cangrelor to Clopidogrel Standard of Care Therapy in Subjects Who Require Percutaneous Coronary ...
Angiographic predictors of 2‐year stent thrombosis in patients receiving drug‐eluting stents: Insights from the ADAPT‐DES study - Généreux - 2017 - Catheterization and Cardiovascular Interventions - Wiley Online Library
Novel Antiplatelet Therapies for Atherothrombotic Diseases | Arteriosclerosis, Thrombosis, and Vascular Biology
Rapamune (Sirolimus) Market Share, Size 2020 By Industry Future Demand, Global Research, Top Leading Players, Developing Trends, Region Forecast To 2026 | News Break
Impact of Intra-procedural Stent Thrombosis during Percutaneous Coronary Intervention: Insights from the CHAMPION PHOENIX Trial. | Request PDF
